Preclinical target validation using patient-derived cells

Nat Rev Drug Discov. 2015 Mar;14(3):149-50. doi: 10.1038/nrd4565. Epub 2015 Feb 20.

Abstract

The Structural Genomics Consortium (SGC) and its clinical, industry and disease-foundation partners are launching open-source preclinical translational medicine studies.

MeSH terms

  • Cell Line*
  • Drug Evaluation, Preclinical / methods*
  • Humans
  • Patients
  • Primary Cell Culture*
  • Public-Private Sector Partnerships
  • Translational Research, Biomedical